Nonalcoholic fatty liver disease: pathology and pathogenesis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annual Review of Pathology

• Publication date

  2010-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1146/annurev-pathol-121808-102132PMID 20078219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alcoholic liver disease.

  2012cited by this paper
• Nonalcoholic fatty liver disease.

  2010cited by this paper
• Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study

  2009cited by this paper
• Quantitative analysis of T2‐correction in single‐voxel magnetic resonance spectroscopy of hepatic lipid fraction

  2009cited by this paper
• VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice

  2009cited by this paper
• Compartmentalization of proteins in lipid droplet biogenesis.

  2009cited by this paper
• Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis

  2009cited by this paper
• Epithelial–mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia

  2009cited by this paper
• Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease

  2009cited by this paper
• Ethnic differences in hepatic steatosis: An insulin resistance paradox?

  2009cited by this paper
• Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

  2009cited by this paper
• Inflammation and Race and Gender Differences in Computerized Tomography‐measured Adipose Depots

  2009cited by this paper
• Nonalcoholic fatty liver disease and cardiovascular risk

  2009cited by this paper
• CHAPTER 41 – Fatty Liver Disease

  2009cited by this paper
• Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

  2008cited by this paper
• Dietary sugars stimulate fatty acid synthesis in adults.

  2008cited by this paper
• Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders

  2008cited by this paper
• Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis

  2008cited by this paper
• Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.

  2008cited by this paper
• Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.

  2008cited by this paper
• Influence of Insulin Resistance and Adipokines in the Grade of Steatosis of Nonalcoholic Fatty Liver Disease

  2008cited by this paper
• A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)

  2008cited by this paper
• Identification and characterization of metabolically benign obesity in humans.

  2008cited by this paper
• Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels.

  2008cited by this paper
• The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease.

  2008cited by this paper
• Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.

  2008cited by this paper
• Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.

  2008cited by this paper
• Fructose consumption as a risk factor for non-alcoholic fatty liver disease.

  2008cited by this paper
• Mechanisms of disease progression in nonalcoholic fatty liver disease.

  2008influential reference
• NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men

  2008cited by this paper
• Fat-specific Protein 27 Regulates Storage of Triacylglycerol*

  2008influential reference
• Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.

  2008cited by this paper
• A core gut microbiome in obese and lean twins

  2008cited by this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cited by this paper
• The genetic background modulates susceptibility to mouse liver Mallory‐Denk body formation and liver injury

  2008cited by this paper
• Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis

  2008cited by this paper
• Visceral fat: A key mediator of steatohepatitis in metabolic liver disease

  2008cited by this paper
• Differential pattern of lipid droplet‐associated proteins and de novo perilipin expression in hepatocyte steatogenesis

  2008cited by this paper
• Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

  2008cited by this paper
• Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study

  2008cited by this paper
• Consequences of lipid droplet coat proteins down – regulation in liver cells : Abnormal lipid droplet metabolism and induction of insulin resistance

  2008influential reference
• Genes and nonalcoholic fatty liver disease

  2008cited by this paper
• Insulin resistance and steatosis in humans.

  2008cited by this paper
• Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation.

  2008cited by this paper
• Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease

  2008cited by this paper
• Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations.

  2008cited by this paper
• The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences.

  2008cited by this paper
• Consequences of Lipid Droplet Coat Protein Downregulation in Liver Cells

  2008cited by this paper
• Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? A Cross-Sectional Comparison With Adult Treatment Panel III Criteria in Nonobese Nondiabetic Subjects

  2008cited by this paper
• Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.

  2008cited by this paper
• Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease.

  2008cited by this paper
• Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey.

  2008cited by this paper
• Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive

  2008cited by this paper
• Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis

  2008influential reference
• The lysosomal‐mitochondrial axis in free fatty acid–induced hepatic lipotoxicity

  2008influential reference
• Animal models of NASH: Getting both pathology and metabolic context right

  2008cited by this paper
• The metabolic syndrome.

  2008cited by this paper
• Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?

  2008influential reference
• Soft drink consumption linked with fatty liver in the absence of traditional risk factors.

  2008cited by this paper
• Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial

  2008cited by this paper
• Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

  2008cited by this paper
• Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis

  2008cited by this paper
• Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis

  2007cited by this paper
• From Mallory to Mallory-Denk bodies: what, how and why?

  2007cited by this paper
• Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet

  2007cited by this paper
• Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory‐Denk bodies

  2007cited by this paper
• Palmitic acid induces production of proinflammatory cytokine interleukin‐8 from hepatocytes

  2007cited by this paper
• 34: Presence of the metabolic syndrome (MS) in obese adolescents predicts impaired glucose tolerance (IGT) and fatty liver disease

  2007cited by this paper
• Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

  2007cited by this paper
• Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.

  2007cited by this paper
• Good fat/bad fat

  2007cited by this paper
• Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats

  2007influential reference
• A lipidomic analysis of nonalcoholic fatty liver disease

  2007cited by this paper
• Obesity and diabetes in the developing world--a growing challenge.

  2007cited by this paper
• Adipokines and cytokines in non‐alcoholic fatty liver disease

  2007influential reference
• HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis

  2007cited by this paper
• Omega 3 - Omega 6: What is right for the liver?

  2007cited by this paper
• Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.

  2007cited by this paper
• Cideb Regulates Diet-Induced Obesity, Liver Steatosis, and Insulin Sensitivity by Controlling Lipogenesis and Fatty Acid Oxidation

  2007cited by this paper
• The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

  2007cited by this paper
• Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans

  2007cited by this paper
• The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis

  2007cited by this paper
• Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

  2007influential reference
• Non-alcoholic steatohepatitis in children.

  2007cited by this paper
• Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

  2006cited by this paper
• The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity.

  2006cited by this paper
• Alcoholic liver disease.

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• Prevalence of Fatty Liver in Children and Adolescents

  2006cited by this paper
• Apoptosis and necrosis in the liver: A tale of two deaths?

  2006cited by this paper
• Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.

  2006cited by this paper
• Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis

  2006cited by this paper
• Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.

  2006cited by this paper
• NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice

  2006cited by this paper
• Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C

  2006cited by this paper
• From fat to inflammation.

  2006cited by this paper
• New treatments for nonalcoholic fatty liver disease

  2006cited by this paper
• In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

  2006cited by this paper
• Non-alcoholic steatohepatitis: from cell biology to clinical practice.

  2006cited by this paper
• Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease.

  2006cited by this paper

• Foods, herbs, and phytoconstituents in alleviating metabolic dysfunction-associated fatty liver disease: A review

  2026cites this paper
• Clinical and Etiological Profile of Chronic Liver Diseases in Children Attending a Tertiary Care Centre

  2026cites this paper
• Self-assembled PEGylated nanoparticles based on Elafibranor derivative 3d for the treatment of metabolic dysfunction-associated steatohepatitis.

  2026cites this paper
• Lonidamine ameliorates MASH by reducing SREBP1 and inhibiting the MAPK pathway.

  2026cites this paper
• Liver Biopsy in Metabolic-Associated Steatotic Liver Disease: Accuracy, Challenges, and Alternatives

  2026cites this paper
• Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization

  2025cites this paper
• Effect of dietary supplementation with raw and boiled ginger (Zingiber officinale Roscoe) rhizome on biochemical parameters of rats fed high cholesterol diet

  2025cites this paper
• Prophylactic oral supplementation of Lactobacillus plantarum CAD suppresses high-fat-diet induced metabolic stress and hepatic complications in Swiss albino mice

  2025cites this paper
• Applications of Danio rerio as a model for studying NAFLD and NASH

  2025cites this paper
• Effect of Supplementation of Antioxidant Lipids Synthetized by Enzymatic Acidolysis with EPA/DHA Concentrate and Maqui (Aristotelia chilensis (Mol.) Stuntz) Seed Oil for Mitigating High-Fat Diet-Induced Obesity and Metabolic Disorders in Mice

  2025cites this paper
• Hallazgos por imagen de las enfermedades hepáticas por depósito

  2025cites this paper
• The individual and synergistic effects of dietary lipids and DHA on the growth performance, feed utilization, lipid metabolism, antioxidant capacity, and immune responses of grass carp (Ctenopharyngodon idellus)

  2025cites this paper
• Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factors, and cardiovascular disease.

  2025cites this paper
• Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH‐Associated Fibrosis

  2025cites this paper
• Liver immunology: Biological role and clinical significance

  2025cites this paper
• FAM172A deletion aggravates high fat diet-induced MASLD via the eIF2α-ATF4-FGF21 loop.

  2025cites this paper
• A Physiological Oxygen Gradient Liver-Zonation-on-a-Chip Reveals HIF-2α Intervention in Hepatic Lipotoxicity.

  2025cites this paper
• Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease

  2025cites this paper
• Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI

  2025cites this paper
• Protective Effects of the Ethyl Acetate Fraction of Distylium racemosum Against Metabolic Dysfunction-Associated Steatohepatitis

  2025cites this paper
• In Vitro and In Vivo Investigation of Biosynthesized Copper Oxide Nanoparticles Using Rose Hip: Characterization and their Potential in Modulating Tubulin and VEGFR-II for Breast Cancer Therapy

  2025cites this paper
• Mechanisms underpinning the effect of exercise on the non-alcoholic fatty liver disease: review

  2025cites this paper
• The Relationship Between Bacterial Changes and Dietary Intervention in Non-Alcoholic Fatty Liver Disease.

  2025cites this paper
• Recent advances in anterior pituitary hormones and metabolic-associated fatty liver disease

  2025cites this paper
• Multi-targeted azacoumarin–cyanocinnamate hybrids induce G2/M arrest and apoptosis via tubulin, and COX-2/VEGFR modulation: insights from in vitro mechanistic basis and in vivo validation

  2025cites this paper
• Non-HDL-C and non-HDL-C/HDL-C ratio as predictors of hepatic steatosis: a systematic review and meta-analysis

  2025cites this paper
• Prevalence and Risk Factors of Type 2 Diabetes Mellitus among Depression Inpatients from 2005 to 2018 in Beijing, China

  2025cites this paper
• Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease

  2025cites this paper
• Increased serum anti-angiogenic factor levels in insulin-resistant obese children and adolescents with or without liver steatosis (NAFL)

  2025cites this paper
• Harnessing lactobacillus: a probiotic revolution in combating metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Patient-derived organoids inform pharmacogenomic vulnerabilities in liver cancer

  2025cites this paper
• LEADS - a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing.

  2025cites this paper
• Exercise ameliorates nonalcoholic fatty liver disease by reducing the IGFBP5 to IGF1 ratio to activate AMPK pathway

  2025cites this paper
• The predictive role of the platelet-to-lymphocyte ratio for the risk of non-alcoholic fatty liver disease and cirrhosis: a nationwide cross-sectional study

  2024cites this paper
• Fatty acids and epigenetics in health and diseases

  2024cites this paper
• Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment

  2024cites this paper
• Tenovin-1, a Selective SIRT1/2 Inhibitor, Attenuates High-fat Diet-induced Hepatic Fibrosis via Inhibition of HSC Activation in ZDF Rats

  2024cites this paper
• Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries.

  2024cites this paper
• Male LEW.1WR1 Rats Develop Metabolic Dysfunction, Steatohepatitis, and Liver Damage

  2024cites this paper
• miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression

  2024cites this paper
• Effect of gut microbiota and PNPLA3 polymorphisms on nonalcoholic fatty liver disease in lean and obese individuals

  2024cites this paper
• Differences in diacylglycerol acyltransferases expression patterns and regulation cause distinct hepatic triglyceride deposition in fish

  2024cites this paper
• An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

  2024influential citation
• Association between Korean Healthy Eating Index and abdominal obesity in Korean adults: the mediating effect of high-sensitivity C-reactive protein

  2024cites this paper
• Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD

  2024cites this paper
• Environmental Obesogens and Their Perturbations in Lipid Metabolism

  2024cites this paper
• Galectin-3 in metabolic disorders: mechanisms and therapeutic potential.

  2024cites this paper
• DA-6034 ameliorates hepatic steatosis and inflammation in high fat diet-induced obese mice

  2024cites this paper
• Ishimozuku (Sphaerotrichia firma) lipids containing fucoxanthin suppress fatty liver and improve short chain fatty acid production in obese model mice

  2024cites this paper
• The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2024cites this paper
• Rodent model of metabolic dysfunction‐associated fatty liver disease: a systematic review

  2024cites this paper
• Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr−/−.Leiden mice

  2024cites this paper
• Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal–regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatment

  2024cites this paper
• Caffeine mitigates tamoxifen-induced fatty liver in Wistar rats

  2024cites this paper
• Correlation between ultrasonography and MR proton density fat fraction techniques in evaluating the severity of liver steatosis

  2024cites this paper
• Effects of repeated weight cycling on non‐alcoholic steatohepatitis in diet‐induced obese mice

  2024cites this paper
• Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy.

  2024cites this paper
• Roles of X-box binding protein 1 in liver pathogenesis

  2024cites this paper
• Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice

  2024cites this paper
• Changes in proteomic cargo of circulating extracellular vesicles in response to lifestyle intervention in adolescents with hepatic steatosis.

  2024cites this paper
• Effect of Antidepressants on Non-Alcoholic Fatty Liver Disease and their Underlying Mechanism.

  2024cites this paper
• MicroRNA-122 regulates inflammatory and autophagic proteins by downregulating pyruvate kinase M2 in non-alcoholic fatty liver disease

  2024cites this paper
• Therapeutic Potential of Herbal medicine against Non-alcoholic Fatty Liver Disease.

  2023cites this paper
• Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progression

  2023cites this paper
• Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric Obesity

  2023cites this paper
• Recognizing Mitochondrial Hepatopathy in Acute Fatty Liver of Pregnancy

  2023cites this paper
• Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis

  2023cites this paper
• Prevalence of non-alcoholic fatty liver disease in overweight and obese children seeking ambulatory healthcare in Nairobi, Kenya

  2023cites this paper
• Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review

  2023cites this paper
• Effects of Intermittent Fasting on Splenic Galectin-3 Protein Expression in High-fat Diet-fed Mice

  2023cites this paper
• Ameliorative Effect of Enhydra fluctuans on Liver Damage in Diabetic Rats

  2023cites this paper
• Fu Brick Tea as a Staple Food Supplement Attenuates High Fat Diet Induced Obesity in Mice

  2023cites this paper
• LncRNA LINK‐A Remodels Tissue Inflammatory Microenvironments to Promote Obesity

  2023cites this paper
• The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients

  2023cites this paper
• Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis

  2023cites this paper
• Macrophage metabolism in nonalcoholic fatty liver disease

  2023cites this paper
• Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

  2023cites this paper
• A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation

  2023cites this paper
• Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial

  2023cites this paper
• Fatty infiltration of the pancreas: a systematic concept analysis

  2023cites this paper
• Effect of nano-micelle curcumin on hepatic enzymes: A new treatment approach for non-alcoholic fatty liver disease (NAFLD)

  2023cites this paper
• Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice

  2023cites this paper
• Non-Alcoholic Fatty Liver Disease (NAFLD): Molecular Mechanism, Pathological Progression and Treatment

  2023cites this paper
• Visceral fat: A key mediator of NAFLD development and progression

  2023cites this paper
• Hepatic Fat and Macrophages Are Increased in Livers of Diabetic Patients without Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation

  2023cites this paper
• Acyl CoA oxidase: from its expression, structure, folding, and import to its role in human health and disease

  2023influential citation
• Application of multiple-finding segmentation utilizing Mask R-CNN-based deep learning in a rat model of drug-induced liver injury

  2023cites this paper
• Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice

  2023cites this paper
• A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitis

  2023cites this paper
• Therapeutic mechanisms of the medicine and food homology formula Xiao-Ke-Yin on glucolipid metabolic dysfunction revealed by transcriptomics, metabolomics and microbiomics in mice

  2023cites this paper
• Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice

  2023cites this paper
• From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria

  2023cites this paper
• Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective

  2023cites this paper
• Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis

  2023cites this paper
• Diets, Gut Microbiota and Metabolites

  2023cites this paper
• Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus

  2023cites this paper
• Bioactive Compounds as Inhibitors of Inflammation, Oxidative Stress and Metabolic Dysfunctions via Regulation of Cellular Redox Balance and Histone Acetylation State

  2023cites this paper